Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection

OBJECTIVE: This study aimed to evaluate the diagnostic performance of the Abbott Architect SARS-CoV-2 IgG assay in COVID-19 patients. METHODS: Residual sera from 177 symptomatic SARS-CoV-2-positive patients and 163 non-COVID-19 patients were tested for antibody with the Abbott SARS-CoV-2 IgG assay (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chew, K.L., Tan, S.S., Saw, S., Pajarillaga, A., Zaine, S., Khoo, C., Wang, W., Tambyah, P., Jureen, R., Sethi, S.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282795/
https://www.ncbi.nlm.nih.gov/pubmed/32531475
http://dx.doi.org/10.1016/j.cmi.2020.05.036

Ejemplares similares

Ejemplares similares